Carbonic Anhydrase Activation Is Associated With Worsened Pathological Remodeling in Human Ischemic Diabetic Cardiomyopathy
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Background: Diabetes mellitus ( DM ) has multifactorial detrimental effects on myocardial tissue. Recently, carbonic anhydrases ( CAs ) have been shown to play a major role in diabetic microangiopathy but their role in the diabetic cardiomyopathy is still unknown. Methods and Results: We obtained left ventricular samples from patients with DM type 2 (DM‐T2) and nondiabetic ( NDM ) patients with postinfarct heart failure who were undergoing surgical coronary revascularization. Myocardial levels of CA ‐I and CA‐ II were 6‐ and 11‐fold higher, respectively, in DM ‐T2 versus NDM patients. Elevated CA ‐I expression was mainly localized in the cardiac interstitium and endothelial cells. CA ‐I induced by high glucose levels hampers endothelial cell permeability and determines endothelial cell apoptosis in vitro. Accordingly, capillary density was significantly lower in the DM ‐T2 myocardial samples (mean± SE =2152±146 versus 4545±211/mm 2 ). On the other hand, CA‐II was mainly upregulated in cardiomyocytes. The latter was associated with sodium‐hydrogen exchanger‐1 hyperphosphorylation, exaggerated myocyte hypertrophy (cross‐sectional area 565±34 versus 412±27 μm 2 ), and apoptotic death (830±54 versus 470±34 per 10 6 myocytes) in DM ‐T2 versus NDM patients. CA‐II is activated by high glucose levels and directly induces cardiomyocyte hypertrophy and death in vitro, which are prevented by sodium‐hydrogen exchanger‐1 inhibition. CA‐II was shown to be a direct target for repression by micro RNA ‐23b, which was downregulated in myocardial samples from DM ‐T2 patients. MicroRNA‐23b is regulated by p38 mitogen‐activated protein kinase, and it modulates high‐glucose CA‐II–dependent effects on cardiomyocyte survival in vitro. Conclusions: Myocardial CA activation is significantly elevated in human diabetic ischemic cardiomyopathy. These data may open new avenues for targeted treatment of diabetic heart failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Myocardial Cell Death in Human Diabetes
Frustaci, A., Kajstura, J., Chimenti, C., Jakoniuk, I., Leri, A., Maseri, A., Nadal-Ginard, B., & Anversa, P. (2000) · Circulation Research · doi:10.1161/01.res.87.12.1123 · Cited by 796
Boudina, S., Bugger, H., Sena, S., O'Neill, B. T., Zaha, V. G., Ilkun, O., Wright, J. J., Mazumder, P. K., Palfreyman, E., Tidwell, T. J., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.792101 · Cited by 301
Dries, D. L., Sweitzer, N. K., Drazner, M. H., Stevenson, L. W., & Gersh, B. J. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01408-5 · Cited by 286 · cited 1×
“excess morbidity and mortality for coronary artery disease (CAD) and post–myocardial infarction (MI) heart failure.(2,3)”
BackgroundRevisiting the links between glycaemia, diabetes and cardiovascular disease
Sattar, N. (2013) · Diabetologia · doi:10.1007/s00125-012-2817-5 · Cited by 163 · cited 1×
“T he global prevalence of diabetes mellitus (DM) is forecast to reach 300 million by 2025, and more than three-fourths of deaths among this population are expected to result from cardiovascular disease.(1) Individuals with DM are indeed at a significantly greater risk of developing both microvascular and macrovascular…”
Cited by
The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms
Salvatore, T., Pafundi, P. C., Galiero, R., Albanese, G., Di Martino, A., Caturano, A., Vetrano, E., Rinaldi, L., & Sasso, F. C. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.695792 · Cited by 165
Self-citationCan Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects
Salvatore, T., Pafundi, P. C., Galiero, R., Rinaldi, L., Caturano, A., Vetrano, E., Aprea, C., Albanese, G., Di Martino, A., Ricozzi, C., et al. (2020) · Biomedicines · doi:10.3390/biomedicines9010003 · Cited by 97
Self-citationPreston, C. C., Larsen, T. D., Eclov, J. A., Louwagie, E. J., Gandy, T. C. T., Faustino, R. S., & Baack, M. L. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.570846 · Cited by 22
“In vitro studies confirm that hyperglycemia increases expression of CA-1 in endothelial cells to disrupt vasculogenesis (87).”
Background
Metadata
- Authors
- Torella, D., Ellison, G. M., Torella, M., Vicinanza, C., Aquila, I., Iaconetti, C., Scalise, M., Marino, F., Henning, B. J., Lewis, F. C., Gareri, C., Lascar, N., Cuda, G., Salvatore, T., Nappi, G., Indolfi, C., Torella, R., Cozzolino, D., & Sasso, F. C.
- Venue
- Journal of the American Heart Association
- Published
- 2014-03-24
- Volume
- 3
- Issue
- 2
- Pages
- e000434-e000434
- ISSN
- 2047-9980 (ISSN-L)
- OpenAlex
- W2124249612
- Cited by
- 99
- References
- 4
- FWCI
- 1.95
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Carbonic Anhydrase Activation Is Associated With Worsened Pathological Remodeling in Human Ischemic Diabetic Cardiomyopathy. https://app.cochat.ai/papers/10.1161/jaha.113.000434
- The paper
- Torella, D., Ellison, G. M., Torella, M., Vicinanza, C., Aquila, I., Iaconetti, C., Scalise, M., Marino, F., Henning, B. J., Lewis, F. C., Gareri, C., Lascar, N., Cuda, G., Salvatore, T., Nappi, G., Indolfi, C., Torella, R., Cozzolino, D., & Sasso, F. C. (2014). Carbonic Anhydrase Activation Is Associated With Worsened Pathological Remodeling in Human Ischemic Diabetic Cardiomyopathy. Journal of the American Heart Association. https://doi.org/10.1161/jaha.113.000434
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.